Literature DB >> 15784794

Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue.

Julienne E Bower1, Patricia A Ganz, Najib Aziz.   

Abstract

OBJECTIVE: Fatigue is one of the most common and distressing symptoms experienced by cancer patients and survivors. However, the etiology of cancer-related fatigue has not been determined. In previous studies, we have shown alterations in morning serum cortisol levels and diurnal cortisol rhythms in fatigued breast cancer survivors compared with nonfatigued control subjects. The purpose of the current study was to evaluate cortisol responses to an experimental psychologic stressor in fatigued and nonfatigued survivors.
METHODS: Participants included 27 breast cancer survivors (11 fatigued, 16 nonfatigued). All had completed cancer treatment at least 3 years previously and were currently healthy with no evidence of recurrence. A standardized laboratory stressor, the Trier Social Stress Test (TSST), was administered during a 90-minute afternoon session. Saliva samples and autonomic measures (heart rate, blood pressure) were collected at 15-minute intervals throughout the session.
RESULTS: Fatigued survivors showed a significantly blunted cortisol response to the stressor compared with nonfatigued survivors, controlling for depression and other potential confounds (p <.05). No differences in autonomic measures were observed.
CONCLUSIONS: These results, together with our earlier findings, suggest a dysregulation in hypothalamic-pituitary-adrenal (HPA) axis responsiveness among breast cancer survivors with enduring fatigue. Although the sample size was small, results suggest that attention to the HPA axis may be important for understanding cancer-related fatigue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784794     DOI: 10.1097/01.psy.0000155666.55034.c6

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  68 in total

1.  Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancer.

Authors:  Nicholas Courtier; Tina Gambling; Stephanie Enright; Peter Barrett-Lee; Jacinta Abraham; Malcolm D Mason
Journal:  Support Care Cancer       Date:  2012-05-28       Impact factor: 3.603

Review 2.  Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.

Authors:  Julienne E Bower; Donald M Lamkin
Journal:  Brain Behav Immun       Date:  2012-07-06       Impact factor: 7.217

3.  Effect of Baduanjin Qigong Exercise on Cancer-Related Fatigue in Patients with Colorectal Cancer Undergoing Chemotherapy: A Randomized Controlled Trial.

Authors:  Yun Lu; Hui-Qin Qu; Feng-Ying Chen; Xiao-Ting Li; Lan Cai; Shan Chen; Yuan-Yuan Sun
Journal:  Oncol Res Treat       Date:  2019-07-02       Impact factor: 2.825

Review 4.  Cancer-related fatigue: links with inflammation in cancer patients and survivors.

Authors:  Julienne E Bower
Journal:  Brain Behav Immun       Date:  2007-05-31       Impact factor: 7.217

Review 5.  A Taxonomy of Fatigue Concepts and Their Relation to Hearing Loss.

Authors:  Benjamin W Y Hornsby; Graham Naylor; Fred H Bess
Journal:  Ear Hear       Date:  2016 Jul-Aug       Impact factor: 3.570

6.  Identifying clinically meaningful fatigue with the Fatigue Symptom Inventory.

Authors:  Kristine A Donovan; Paul B Jacobsen; Brent J Small; Pamela N Munster; Michael A Andrykowski
Journal:  J Pain Symptom Manage       Date:  2008-05-20       Impact factor: 3.612

Review 7.  The role of neuro-immune interactions in cancer-related fatigue: Biobehavioral risk factors and mechanisms.

Authors:  Julienne E Bower
Journal:  Cancer       Date:  2019-01-02       Impact factor: 6.860

8.  A clinically translatable mouse model for chemotherapy-related fatigue.

Authors:  Jonathan A Zombeck; Edward G Fey; Gregory D Lyng; Stephen T Sonis
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

9.  Correlation between hemoglobin and fatigue in women undergoing adjuvant chemotherapy without erythropoietin-stimulating-agent support.

Authors:  Sarah Blair; Wayne A Bardwell; Yaffa Podbelewicz-Schuller; Joanne E Mortimer
Journal:  Clin Breast Cancer       Date:  2008-12       Impact factor: 3.225

Review 10.  Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.

Authors:  Andrew H Miller; Sonia Ancoli-Israel; Julienne E Bower; Lucile Capuron; Michael R Irwin
Journal:  J Clin Oncol       Date:  2008-02-20       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.